Viemed Healthcare Files 8-K
Ticker: VMD · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1729149
| Field | Detail |
|---|---|
| Company | Viemed Healthcare, Inc. (VMD) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-statements
Related Tickers: VMD
TL;DR
Viemed Healthcare filed a standard 8-K, no major news yet.
AI Summary
On March 11, 2024, Viemed Healthcare, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard regulatory filing.
Why It Matters
This filing is a routine update for Viemed Healthcare, Inc., informing the SEC about financial statements and exhibits, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, indicating no immediate material adverse events.
Key Players & Entities
- VIEMED HEALTHCARE, INC. (company) — Registrant
- 0001729149-24-000079 (filing_id) — Accession Number
- March 11, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for Viemed Healthcare, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Viemed Healthcare, Inc.
On what date was this 8-K report filed?
The report was filed on March 11, 2024.
What is the principal executive office address for Viemed Healthcare, Inc.?
The address of the principal executive offices is 625 E. Kaliste Saloom Rd., Lafayette, Louisiana 70508.
What is the telephone number for Viemed Healthcare, Inc.?
The registrant's telephone number is (337) 504-3802.
Filing Stats: 647 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-03-11 16:47:37
Filing Documents
- vmd-20240311.htm (8-K) — 31KB
- investorpresentationmarc.htm (EX-99.1) — 31KB
- investorpresentationmarc001.jpg (GRAPHIC) — 58KB
- investorpresentationmarc002.jpg (GRAPHIC) — 230KB
- investorpresentationmarc003.jpg (GRAPHIC) — 87KB
- investorpresentationmarc004.jpg (GRAPHIC) — 110KB
- investorpresentationmarc005.jpg (GRAPHIC) — 102KB
- investorpresentationmarc006.jpg (GRAPHIC) — 115KB
- investorpresentationmarc007.jpg (GRAPHIC) — 114KB
- investorpresentationmarc008.jpg (GRAPHIC) — 74KB
- investorpresentationmarc009.jpg (GRAPHIC) — 100KB
- investorpresentationmarc010.jpg (GRAPHIC) — 120KB
- investorpresentationmarc011.jpg (GRAPHIC) — 99KB
- investorpresentationmarc012.jpg (GRAPHIC) — 106KB
- investorpresentationmarc013.jpg (GRAPHIC) — 133KB
- investorpresentationmarc014.jpg (GRAPHIC) — 115KB
- investorpresentationmarc015.jpg (GRAPHIC) — 111KB
- investorpresentationmarc016.jpg (GRAPHIC) — 36KB
- investorpresentationmarc017.jpg (GRAPHIC) — 95KB
- investorpresentationmarc018.jpg (GRAPHIC) — 96KB
- investorpresentationmarc019.jpg (GRAPHIC) — 94KB
- investorpresentationmarc020.jpg (GRAPHIC) — 104KB
- investorpresentationmarc021.jpg (GRAPHIC) — 82KB
- investorpresentationmarc022.jpg (GRAPHIC) — 84KB
- investorpresentationmarc023.jpg (GRAPHIC) — 94KB
- investorpresentationmarc024.jpg (GRAPHIC) — 30KB
- investorpresentationmarc025.jpg (GRAPHIC) — 129KB
- 0001729149-24-000079.txt ( ) — 3670KB
- vmd-20240311.xsd (EX-101.SCH) — 2KB
- vmd-20240311_lab.xml (EX-101.LAB) — 21KB
- vmd-20240311_pre.xml (EX-101.PRE) — 12KB
- vmd-20240311_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure Viemed Healthcare, Inc. (the "Company") expects to use the presentation attached to this Current Report on Form 8-K as Exhibit 99.1 (the "Investor Deck Presentation") and incorporated herein by reference, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others. The Investor Deck Presentation is also available on the Company's website, https://www.viemed.com/investors. The information contained in the Investor Deck Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission ("SEC") filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, except as required by law although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure. The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Viemed Investor Deck Presentation March 2024 104 Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 11, 2024 VIEMED HEALTHCARE, INC. By: /s/ Trae Fitzgerald Trae Fitzgerald Chief Financial Officer